JP5063860B2 - 抗寄生虫活性を有する化合物及びそれを含有する医薬 - Google Patents

抗寄生虫活性を有する化合物及びそれを含有する医薬 Download PDF

Info

Publication number
JP5063860B2
JP5063860B2 JP2004522264A JP2004522264A JP5063860B2 JP 5063860 B2 JP5063860 B2 JP 5063860B2 JP 2004522264 A JP2004522264 A JP 2004522264A JP 2004522264 A JP2004522264 A JP 2004522264A JP 5063860 B2 JP5063860 B2 JP 5063860B2
Authority
JP
Japan
Prior art keywords
mmol
bis
water
nmr
mhz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004522264A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504652A (ja
Inventor
ヴィアル,アンリ
カラ,ミッシェル
エスカール,ロジェール
ヴィダル,ヴァレリ
ブルゾール,フランソワーズ
アンスラーン,マリ−ロール
Original Assignee
サーントル ナシオナル ドゥ ラ ルシェルシェ シャーンティフィク(セーエンヌエールエス)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サーントル ナシオナル ドゥ ラ ルシェルシェ シャーンティフィク(セーエンヌエールエス) filed Critical サーントル ナシオナル ドゥ ラ ルシェルシェ シャーンティフィク(セーエンヌエールエス)
Publication of JP2006504652A publication Critical patent/JP2006504652A/ja
Application granted granted Critical
Publication of JP5063860B2 publication Critical patent/JP5063860B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2004522264A 2002-07-18 2003-07-18 抗寄生虫活性を有する化合物及びそれを含有する医薬 Expired - Fee Related JP5063860B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0209156A FR2842423B1 (fr) 2002-07-18 2002-07-18 Composes a activite anti-parasitaire et medicaments les renfermant
FR02/09156 2002-07-18
PCT/FR2003/002283 WO2004009068A2 (fr) 2002-07-18 2003-07-18 Composes a activite anti-parasitaire et medicaments les renfermant

Publications (2)

Publication Number Publication Date
JP2006504652A JP2006504652A (ja) 2006-02-09
JP5063860B2 true JP5063860B2 (ja) 2012-10-31

Family

ID=29797562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004522264A Expired - Fee Related JP5063860B2 (ja) 2002-07-18 2003-07-18 抗寄生虫活性を有する化合物及びそれを含有する医薬

Country Status (17)

Country Link
US (1) US8012985B2 (de)
EP (5) EP2260840A3 (de)
JP (1) JP5063860B2 (de)
CN (2) CN1668288B (de)
AP (1) AP2098A (de)
AR (1) AR040504A1 (de)
AU (2) AU2003269035A1 (de)
BR (1) BR0312719A (de)
CA (1) CA2491989C (de)
FR (1) FR2842423B1 (de)
IL (1) IL166036A0 (de)
MX (1) MXPA05000751A (de)
OA (1) OA12888A (de)
PL (1) PL374308A1 (de)
TW (1) TW200412932A (de)
WO (1) WO2004009068A2 (de)
ZA (1) ZA200500250B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6013364B2 (ja) * 2010-12-23 2016-10-25 アルカーメス ファーマ アイルランド リミテッド マルチプルapiローディングプロドラッグ
FR3017240B1 (fr) * 2014-02-04 2016-01-29 Ncs Pyrotechnie Et Tech Sas Coupe-circuit pyrotechnique

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH214041A (fr) 1938-04-14 1941-03-31 May & Baker Ltd Verfahren zur Herstellung von 4.4'-Diamidino-a, y-diphenoxypropan.
US2364075A (en) * 1942-10-15 1944-12-05 Du Pont Disinfectant compounds
US2744116A (en) * 1953-12-04 1956-05-01 Purdue Research Foundation Bis-(aminotriazolyl-)-hydrocarbons
US3020283A (en) * 1958-10-20 1962-02-06 Abbott Lab Bis-lepidines
US3222285A (en) * 1962-07-23 1965-12-07 Union Oil Co Non-corrosive detergent compositions
US3471509A (en) * 1965-06-17 1969-10-07 William J Mckillip Oxadiazoles
FR1542163A (fr) * 1966-10-31 1968-10-11 Toyo Jozo Kk Procédé de fabrication de composés bisamidino substitués et composés obtenus par le procédé précédent ou similaire
GB1197929A (en) * 1966-10-31 1970-07-08 Toyo Jozo Kk Process for the Manufacture of Substituted Bis-AmidinoCompounds
US3639478A (en) * 1968-06-24 1972-02-01 Sterling Drug Inc N n-alkylenebis(2-lower alkoxy) - 2-sub-stituted-alkanamidines) and their preparation
JPS5235300A (en) * 1975-09-12 1977-03-17 Sakai Chem Ind Co Ltd Curing agents for epoxy resins
US4178253A (en) * 1977-04-05 1979-12-11 Ciba-Geigy Corporation Corrosion inhibited lubricant compositions
JPS5748902A (en) 1980-09-10 1982-03-20 Dainippon Ink & Chem Inc Agricultural and horticultural germicide
EP0338372A3 (de) * 1988-04-22 1991-10-09 American Cyanamid Company Solubilisierte Vorstufen von Medikamenten
DE4026473A1 (de) * 1990-08-22 1992-02-27 Basf Ag Bis-guanidine und diese enthaltende fungizide
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
CA2153987A1 (en) * 1993-01-14 1994-07-21 U. Prasad Kari Amino acids and peptides having modified terminals
KR960703856A (ko) * 1994-06-06 1996-08-31 가와노 다케히코 축합 고리를 갖는 카르복실산 화합물, 이의 염 및 이의 약학적 용도(novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof)
GB9515720D0 (en) * 1995-08-01 1995-10-04 Zeneca Ltd Bacterial coating compositions
US5874438A (en) * 1996-10-11 1999-02-23 Bayer Aktiengesellschaft 2,2'-bridged bis-2,4-diaminoquinazolines
EP0836851A1 (de) * 1996-10-21 1998-04-22 Virbac S.A. Amidin-Verbindungen zur Behandlung von durch Ekto- oder Endoparasiten hervorgerufenen Erkrankungen und systemische Zusammensetzungen zur Parasitenkontrolle
JPH10237761A (ja) * 1997-02-21 1998-09-08 Lion Corp 柔軟仕上げ剤組成物
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
JP4090133B2 (ja) * 1998-12-28 2008-05-28 富士フイルム株式会社 抗マラリア剤
JP3459189B2 (ja) * 1999-03-01 2003-10-20 科学技術振興事業団 フェブリフジンおよびイソフェブリフジンとその製造方法
US6544541B1 (en) * 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
EP1545544A2 (de) * 2002-07-11 2005-06-29 Combinatorx, Incorporated Kombinationen von medikamenten für die behandlung von neoplasien

Also Published As

Publication number Publication date
EP2266555A2 (de) 2010-12-29
CN102079729B (zh) 2013-04-24
AR040504A1 (es) 2005-04-06
TW200412932A (en) 2004-08-01
JP2006504652A (ja) 2006-02-09
EP2275100A3 (de) 2013-01-09
EP2260841A3 (de) 2013-01-02
US8012985B2 (en) 2011-09-06
AU2009225272B2 (en) 2012-08-23
OA12888A (fr) 2006-10-13
IL166036A0 (en) 2006-01-15
EP2260841A2 (de) 2010-12-15
AU2003269035A1 (en) 2004-02-09
US20050176819A1 (en) 2005-08-11
CA2491989A1 (fr) 2004-01-29
EP2260840A2 (de) 2010-12-15
EP1524972A2 (de) 2005-04-27
FR2842423B1 (fr) 2005-07-08
TWI369979B (de) 2012-08-11
WO2004009068A3 (fr) 2004-08-12
CN102079729A (zh) 2011-06-01
EP2260840A3 (de) 2013-01-02
ZA200500250B (en) 2006-05-31
AP2098A (en) 2010-02-02
EP2266555A3 (de) 2013-01-09
AU2009225272A1 (en) 2009-10-29
AP2005003224A0 (en) 2005-03-31
MXPA05000751A (es) 2005-04-28
CA2491989C (fr) 2012-03-20
PL374308A1 (pl) 2005-10-03
EP2275100A2 (de) 2011-01-19
WO2004009068A2 (fr) 2004-01-29
CN1668288B (zh) 2013-07-17
FR2842423A1 (fr) 2004-01-23
CN1668288A (zh) 2005-09-14
BR0312719A (pt) 2005-04-26

Similar Documents

Publication Publication Date Title
ES2565229T3 (es) Derivados 2-amino-4-(piridin-2-il)-5,6-dihidro-4H-1,3-oxazina y su uso como inhibidores de BACE-1 y/o BACE-2
JP2020524703A (ja) がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物
CN105541836A (zh) 激酶抑制剂的前药形式及其在治疗中的用途
CN1446217A (zh) 用作磷酸二酯酶抑制剂的β-咔啉衍生物
HUT77735A (hu) Triazinszármazékok és ezeket tartalmazó gyógyászati készítmények
RU2436786C1 (ru) Замещенные индолы, противовирусный активный компонент, способ получения и применения
JP5063860B2 (ja) 抗寄生虫活性を有する化合物及びそれを含有する医薬
AU2011271480B2 (en) Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
CN102796121B (zh) 3-芳基-7H-噻唑并[3,2-b]-1,2,4-三嗪-7-酮类衍生物及其应用
JP3873173B2 (ja) ビス−2−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
JPWO2006082821A1 (ja) ヘルペスウイルスが関与する疾患の予防若しくは治療剤
CN100467440C (zh) 双季铵盐前体及其作为抗寄生物前药的用途
JP4152576B2 (ja) 抗がん剤
KR20180020119A (ko) 새로운 5형포스포디에스테라아제 억제제 및 그 용도
US20050107439A1 (en) Composition and method for treating emesis
KR20260030140A (ko) 헤테로방향족 dhodh 억제제
HK1152495A (en) Compounds with antiparasitic activity and medicines containing same
HK1151978A (en) Compounds with antiparasitic activity and medicines containing same
JP2008543770A (ja) (5z)−5−(6−キノキサリニルメチリデン)−2−[(2,6−ジクロロフェニル)アミノ]−1,3−チアゾール−4(5h)−オン
JP2002536448A (ja) 治療用ヌクレオシド化合物
HK1151977A (en) Compounds with antiparasitic activity and medicines containing same
HK1153387A (en) Compounds with anti-parasitic activity and drugs containing said compounds
JP2000095737A (ja) キノンメチド化合物
JPS61249988A (ja) 新規ピリミドピリミジン誘導体、その製法並びに該化合物を含有する医薬組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090818

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090825

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091016

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120628

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120726

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120808

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150817

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees